{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Testing+Archival+Tumor+Tissue", "query": { "intervention": "Testing Archival Tumor Tissue" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 26, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Testing+Archival+Tumor+Tissue&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T14:57:04.637Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03955913", "title": "A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urothelial Cancer", "Receptors, Fibroblast Growth Factor" ], "interventions": [ { "name": "Archival Tumor Tissue Sample", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3679, "start_date": "2019-08-01", "completion_date": "2022-09-19", "has_results": false, "last_update_posted_date": "2023-02-24", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 23, "location_summary": "Tucson, Arizona • Denver, Colorado • Newark, Delaware + 20 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Newark", "state": "Delaware" }, { "city": "Chicago Ridge", "state": "Illinois" }, { "city": "Brandywine", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03955913" }, { "nct_id": "NCT04857528", "title": "Detecting HPV DNA in Anal and Cervical Cancers", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Cancer", "Anal Cancer", "HPV-Related Anal Squamous Cell Carcinoma", "HPV-Related Cervical Carcinoma", "HPV-Related Carcinoma", "Uterine Cervical Cancer" ], "interventions": [ { "name": "Radiation Treatment With or Without Chemotherapy", "type": "RADIATION" }, { "name": "Blood Sample Collection", "type": "OTHER" }, { "name": "HPV Genotyping (HPV DNA Test)", "type": "DIAGNOSTIC_TEST" }, { "name": "Testing Archival Tumor Tissue", "type": "DIAGNOSTIC_TEST" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "RADIATION", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2020-10-06", "completion_date": "2027-11-15", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 2, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04857528" }, { "nct_id": "NCT06073431", "title": "LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Colorectal Carcinoma", "Advanced Lung Non-Small Cell Carcinoma", "Advanced Pancreatic Adenocarcinoma", "Stage IV Colorectal Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8", "Unresectable Colorectal Carcinoma", "Unresectable Lung Non-Small Cell Carcinoma", "Unresectable Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Medical Device Usage and Evaluation", "type": "OTHER" }, { "name": "Physical Performance Testing", "type": "OTHER" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2023-12-04", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-01-09", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 225, "location_summary": "Fort Smith, Arkansas • Aurora, Colorado • Boulder, Colorado + 160 more", "locations": [ { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Centennial", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06073431" }, { "nct_id": "NCT04743661", "title": "131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Medulloblastoma", "Recurrent Ependymoma" ], "interventions": [ { "name": "Irinotecan", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Omburtamab I-131", "type": "DRUG" }, { "name": "Liothyronine", "type": "DRUG" }, { "name": "SSKI", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Antipyretic", "type": "DRUG" }, { "name": "Antihistamine", "type": "DRUG" }, { "name": "anti-emetics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pediatric Brain Tumor Consortium", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 62, "start_date": "2022-04-04", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 3, "location_summary": "Los Angeles, California • New York, New York • Cincinnati, Ohio", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04743661" }, { "nct_id": "NCT03078036", "title": "International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Germline BRCA Test (blood)", "type": "GENETIC" }, { "name": "FoundationOne Dx Genomic Profile (archival Tumour Specimen)", "type": "GENETIC" }, { "name": "Follow-up", "type": "OTHER" } ], "intervention_types": [ "GENETIC", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 873, "start_date": "2017-03-13", "completion_date": "2019-05-20", "has_results": false, "last_update_posted_date": "2020-05-20", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 14, "location_summary": "Santa Barbara, California • Denver, Colorado • Hialeah, Florida + 10 more", "locations": [ { "city": "Santa Barbara", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "Denton", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03078036" }, { "nct_id": "NCT02435472", "title": "Active Surveillance Exercise Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Localized Prostate Cancer", "Active Surveillance for Prostate Cancer" ], "interventions": [ { "name": "Exercise", "type": "BEHAVIORAL" }, { "name": "Cardiopulmonary Exercise Test (CPET)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 104, "start_date": "2016-06-21", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2025-04-11", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02435472" }, { "nct_id": "NCT03871816", "title": "A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Metastatic Prostate Cancer" ], "interventions": [ { "name": "Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 14532, "start_date": "2019-04-22", "completion_date": "2022-11-22", "has_results": false, "last_update_posted_date": "2023-12-11", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 93, "location_summary": "Homewood, Alabama • Mobile, Alabama • Phoenix, Arizona + 82 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03871816" }, { "nct_id": "NCT03737695", "title": "Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Invasive Breast Carcinoma", "Metastatic Breast Carcinoma", "Peritoneal Effusion", "Recurrent Breast Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Medical Chart Review", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2019-09-16", "completion_date": "2027-09-15", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 14, "location_summary": "Birmingham, Alabama • San Francisco, California • Washington D.C., District of Columbia + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03737695" }, { "nct_id": "NCT01517971", "title": "Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1060, "start_date": "2012-01", "completion_date": "2019-02-27", "has_results": false, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01517971" }, { "nct_id": "NCT05372614", "title": "Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Malignant Solid Neoplasm", "Metastatic Pancreatic Adenocarcinoma", "Stage III Pancreatic Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8", "Unresectable Malignant Solid Neoplasm", "Unresectable Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Neratinib Maleate", "type": "DRUG" }, { "name": "Trastuzumab Deruxtecan", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2022-10-05", "completion_date": "2028-07-17", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-09-07T14:57:04.637Z", "location_count": 18, "location_summary": "Duarte, California • Irvine, California • Lancaster, California + 13 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05372614" } ] }